Latest Period
Q4 2025
Security Snapshot
LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (LSBCF) Institutional Ownership
CUSIP: G9845F208
13F Institutional Holders and Ownership History from Q4 2024 to Q4 2025
Institutions Reporting
0
Shares (Excl. Options)
0
Price
$0.05
- Type / Class
- Equity / Ordinary Shares, par value $0.0002 per share
- Symbol
- LSBCF on OTC
- Shares outstanding
- 41,218,298
- Price per share
- $0.05
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 0
- Total reported value
- $0
- Share change
- -24,757
- Value change
- -$18,075
- Number of holders
- 0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- LSBCF - LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share is tracked under CUSIP G9845F208.
- 0 institutions reported positions in Q4 2025.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 1 to 0 between Q3 2025 and Q4 2025.
- Reported value moved from $18,075 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP G9845F208?
CUSIP G9845F208 identifies LSBCF - LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G9845F208:
Significant Owners of LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (LSBCF) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Crystal Peak Investment Inc. | 51% | 0% | $1,681,707 | 21,021,332 | 0% | Crystal Peak Investment Inc. | 24 Mar 2026 | |
| Wong Fung Ching | 24% | $9,639,290 | 9,836,010 | Fung Ching Wong | 11 Jul 2025 |
As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (LSBCF). This represents 0% of the company’s total 41,218,298 outstanding shares.
Institutional Holders of LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (LSBCF) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 0 | $0 | -$18,075 | $0.05 | 0 |
| 2025 Q3 | 24,757 | $18,075 | -$304,684 | $0.73 | 1 |
| 2025 Q2 | 323,467 | $329,684 | -$120,967 | $1.02 | 7 |
| 2025 Q1 | 1,447,850 | $1,015,183 | +$69,432 | $2.42 | 9 |
| 2024 Q4 | 388,604 | $1,342,686 | +$1,342,686 | $3.45 | 6 |